Siheung-si, South Korea

Uk-Il Kim

USPTO Granted Patents = 3 

 

 

Average Co-Inventor Count = 5.4

ph-index = 1


Location History:

  • Ansan-si, KR (2022)
  • Siheung-si, KR (2019 - 2023)

Company Filing History:


Years Active: 2019-2023

Loading Chart...
Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: **Innovations by Uk-Il Kim: A Pioneer in Antiviral Research**

Introduction

Uk-Il Kim, an esteemed inventor based in Siheung-si, South Korea, has made significant strides in the realm of pharmaceutical innovations. With a total of three patents to his name, his work focuses primarily on developing novel compounds aimed at combating viral infections.

Latest Patents

Among Uk-Il Kim's latest innovations are two notable patents. The first is a groundbreaking patent for "Nucleoside or nucleotide derivatives, and uses thereof," which pertains to a novel nucleoside or nucleotide derivative along with its racemate, stereoisomer, or pharmaceutically acceptable salt. This invention includes a pharmaceutical composition designed for the prevention or treatment of viral infection-associated diseases, utilizing the new derivatives as active ingredients.

His second noteworthy patent is for a "Pyrrolopyridine derivative, method for producing same, and use thereof." This patent introduces an innovative pyrrolopyridine compound, represented by a specific Chemical Formula. The compound exhibits high selectivity and antiviral activity against human immunodeficiency virus (HIV), while maintaining low toxicity levels, demonstrating its potential as a therapeutic agent specifically for HIV infections.

Career Highlights

Uk-Il Kim is currently affiliated with St Pharm Co., Ltd., where he continues to contribute to the field of antiviral research. His academic and professional background supports his innovative approach to problem-solving in pharmaceutical development. His inventions reflect a commitment to improving health outcomes through scientific research.

Collaborations

During his career, Uk-Il Kim has collaborated with talented colleagues, including Kyungjin Kim and Bong Jin Kim, to enhance the research and development processes within his organization. These collaborations not only foster a rich exchange of ideas but also drive the advancement of significant pharmaceutical innovations.

Conclusion

In conclusion, Uk-Il Kim stands out as a prominent inventor in the pharmaceutical sector, particularly in antiviral research. His latest patents highlight the potential for new therapies aimed at treating viral infections, exemplifying the importance of innovation in healthcare. As he continues to explore new avenues in his field, the contributions of Uk-Il Kim are sure to have a lasting impact on medical science and patient care.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…